Tag: Blood Disorders
2022 ICC Recategorization Facilitates Risk Stratification of Myelodysplastic Syndrome
Distinct mutational landscape and poorer outcomes seen for patients with MDS/acute myeloid leukemia versus MDS not otherwise specified
FDA Moves to Ease Restrictions on Gay Men Giving Blood
Administration says it expects to issue updated draft guidance in the coming months
Five-Year Relative Survival 59.6 Percent in Lower-Risk Myelodysplastic Syndromes
Five-year overall survival 47.3 percent in patients with lower-risk myelodysplastic syndromes
FDA Approves First Cell-Based Gene Therapy for Beta-Thalassemia
The single-dose treatment is approved for transfusion-dependent adults and children
Low Serum Urate Level Tied to Low Lean Mass, Underweight
Association of low serum urate with increased mortality not statistically significant after adjusting for body composition
Guideline Updated for Managing Hyperbilirubinemia in Newborns
All families should receive written and verbal education about neonatal jaundice before discharge
COVID-19 Booster May Spur Seroconversion in Blood Cancer Patients
Among nonresponders to initial COVID-19 vaccination, seroconversion occurred in 56 percent following booster dose
Increased Blood Viscosity Linked to Mortality in COVID-19
Hospitalized COVID-19 patients with increased estimated blood viscosity may have greater risk for in-hospital mortality
Donor Sex, Parity Do Not Up Mortality for Red Blood Cell Recipients
After adjustment for donor hemoglobin levels, no increased risk seen for requiring additional transfusion after transfusion from female donor
